Candesartan cilexetil and Ventricular extrasystoles - a phase IV clinical study of FDA data

Summary:

Ventricular extrasystoles is reported as a side effect among people who take Candesartan cilexetil (candesartan cilexetil), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Simvastatin, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Ventricular extrasystoles when taking Candesartan cilexetil. It is created by eHealthMe based on reports of 14,487 people who have side effects when taking Candesartan cilexetil from the FDA, and is updated regularly.

What is Candesartan cilexetil?

Candesartan cilexetil has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 15,294 Candesartan cilexetil users. Check the latest studies of Candesartan cilexetil.

What is Ventricular extrasystoles?

Ventricular extrasystoles (premature cardiac contraction) is found to be associated with 1,242 drugs and 1,239 conditions by eHealthMe. Check the latest studies of Ventricular extrasystoles.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

14,487 people reported to have side effects when taking Candesartan cilexetil.
Among them, 81 people (0.56%) have Ventricular extrasystoles.

Could Candesartan cilexetil cause Ventricular extrasystoles?

Among these 81 people:

How long have people been on Candesartan cilexetil when they have Ventricular extrasystoles? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Ventricular extrasystoles when taking Candesartan cilexetil? *

  • female: 43.59 %
  • male: 56.41 %

What is the age of people who have Ventricular extrasystoles when taking Candesartan cilexetil? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.75 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 12.28 %
  • 60+: 85.96 %

What are other drugs people take besides Candesartan cilexetil? *

  1. Aspirin: 26 people, 32.10%
  2. Simvastatin: 26 people, 32.10%
  3. Allopurinol: 22 people, 27.16%
  4. Torsemide: 21 people, 25.93%
  5. Amlodipine: 20 people, 24.69%
  6. Hydrochlorothiazide: 17 people, 20.99%
  7. Finasteride: 17 people, 20.99%
  8. Losartan Potassium: 17 people, 20.99%
  9. Heparin: 16 people, 19.75%
  10. Flecainide Acetate: 16 people, 19.75%

What are other side effects people have besides Ventricular extrasystoles? *

  1. Mitral Valve Incompetence (inefficient heart valve): 28 people, 34.57%
  2. Drowsiness: 22 people, 27.16%
  3. Joint Pain: 22 people, 27.16%
  4. Dyspnea Exertional: 21 people, 25.93%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 23.46%
  6. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 19 people, 23.46%
  7. Aortic Valve Incompetence: 19 people, 23.46%
  8. Nausea (feeling of having an urge to vomit): 18 people, 22.22%
  9. Loss Of Consciousness: 18 people, 22.22%
  10. Haematuria (presence of blood in urine): 17 people, 20.99%

What are the existing conditions these people have? *

  1. Asthma: 10 people, 12.35%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 12.35%
  3. Cardiac Failure: 9 people, 11.11%
  4. Congestive Cardiomyopathy (weakening of heart muscle): 9 people, 11.11%
  5. Myocarditis (inflammation of heart muscle myocardium): 8 people, 9.88%
  6. Local Anaesthesia: 8 people, 9.88%
  7. Anaesthesia: 7 people, 8.64%
  8. Tinnitus (a ringing in the ears): 6 people, 7.41%
  9. Pharyngitis (inflammation of the pharynx, causing a sore throat): 6 people, 7.41%
  10. Oropharyngeal Pain: 6 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Candesartan cilexetil and have Ventricular extrasystoles?

- Check whether Ventricular extrasystoles is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Candesartan cilexetil:

Ventricular extrasystoles treatments and more:

How severe was Ventricular extrasystoles and when was it recovered:

Expand to all the drugs that have ingredients of candesartan cilexetil:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Candesartan cilexetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular extrasystoles:

Browse all the conditions that are associated with Ventricular extrasystoles:


How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Candesartan cilexetil) and Candesartan cilexetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: